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Abstract
Background: Evidence exists pointing out how non-adherence to treatment remains a major hurdle to efficient
tuberculosis control in developing countries. Many tuberculosis (Tb) patients do not complete their six-month
course of anti-tuberculosis medications and are not aware of the importance of sputum re-examinations, thereby
putting themselves at risk of developing multidrug-resistant and extensively drug-resistant forms of tuberculosis
and relapse. However, there is a dearth of publications about non-adherence towards anti-Tb medication in these
settings. We assessed the prevalence of and associated factors for anti-Tb treatment non-adherence in public health
care facilities of South Ethiopia.
Methods: This was a cross-sectional survey using both quantitative and qualitative methods. The quantitative study
was conducted among 261 Tb patients from 17 health centers and one general hospital. The qualitative aspect
included an in-depth interview of 14 key informants. For quantitative data, the analysis of descriptive statistics,
bivariate and multiple logistic regression was carried out, while thematic framework analysis was applied for the
qualitative data.
Results: The prevalence of non-adherence towards anti-Tb treatment was 24.5%. Multiple logistic regression
analysis demonstrated that poor knowledge towards tuberculosis and its treatment (AOR = 4.6, 95%CI: 1.4-15.6),
cost of medication other than Tb (AOR = 4.7, 95%CI: 1.7-13.4), having of health information at every visit (AOR = 3,
95% CI: 1.1-8.4) and distance of DOTS center from individual home (AOR = 5.7, 95%CI: 1.9-16.8) showed statistically
significant association with non-adherence towards anti- tuberculosis treatment. Qualitative study also revealed that
distance, lack of awareness about importance of treatment completion and cost of transportation were the major
barriers for adherence.
Conclusions: A quarter of Tb patients interrupted their treatment due to knowledge, availability and accessibility of
DOTS service. We recommend creating awareness about anti-Tb treatment, and decentralization of drug pick-ups to
the lowest level of health institutions.
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Background
Evidence exists that tuberculosis (Tb) is a major public
health problem throughout the world, with an estimated
9.6 million annual incident cases, of which 1.2 million
(12%) were co-infected with HIV and 1.5 million died
globally in 2014 [1]. South East Asia (29%) and Africa
(26%) accounted for the highest number of Tb cases,
and both continents also shared 75% of global Tb deaths
[2]. India, china and South Africa are countries with the
highest burden of Tb accounting for 1.98 million [3], 1.4
million [2] and 0.5 million [4] respectively.
Standard Tb treatment requires patients to take a
complex combination of drugs for 2 months in intensive
phase and 4 months in continuation phase for new pa-
tients [5]. In the treatment of patients with MDR-Tb, an
intensive phase of at least 8 months and a total treat-
ment duration of at least 24 months is recommended
[5]. This leads to non-adherence towards anti-Tb treat-
ment. Directly observed therapy short course (DOTS),
the use of the most effective standardized, short-course
regimen, and of fixed-dose drug combinations (FDCs)
under observation of health workers or family members,
was the key strategy to improve adherence to anti-Tb
treatment [5]. Ethiopia subscribed to the internationally
accepted World Health Organization (WHO) strategy
for Tb control and the DOTS programme was imple-
mented since 1997 [5]. Nevertheless, coverage of DOTS
service was still minimal and made little progress on
treatment adherence in some resource- meager coun-
tries such as Ethiopia [6–8].
Even with over 80 million dollar USD funding from
international agencies, and with counterpart funding
from the Ethiopian government annually, Tb control re-
mains modest [9]. Ethiopia, ranked 8th place, had 261
incident and 394 prevalent cases per 100,000 popula-
tions in 2010 [10]. A prevalence rate of 28.6% Tb/HIV
co-infection [8] and 15.3% MDR-Tb was reported in the
country [11]. Non-adherence to Tb treatment was well
thought out an important barrier to Tb control [12]. It
causes treatment failure and Tb relapse, and can further
lead to prolonged infection, transmission, drug resist-
ance and mortality [13].
In Ethiopia, different studies assessed the rates and de-
terminants of anti-Tb non-adherence. For example, a
study conducted North Ethiopia reported a prevalence
rate of 11.5% [14]. Another study from Northwest
Ethiopia reported a prevalence rate of 18.3% [15]. Being
positive for human immunodeficiency virus (HIV), being
on re-treatment for anti-Tb, knowledge about the dis-
ease, forgetfulness, social and economic factors played a
role in patients’ refusal to comply with ant-Tb treatment
[14–16]. However, most evidences come from retro-
spective surveys, few study settings, and solely from
quantitative evidences. Thus, we assessed the prevalence
of and factors associated for non-adherence towards
anti-Tb treatment in 18 health care facilities in South
Ethiopia using mixed methods.
Methods
Study design, settings and participants
This was an institution based cross-sectional survey that
mixed quantitative and qualitative methods. We
followed the guidelines on programmatic management
of tuberculosis in Ethiopia for diagnosis and classifica-
tion of Tb cases [5]. The zone is locate in Southern Na-
tion, Nationalities and Peoples Region (SNNPR) and is
500 km far from Addis Ababa, Capital city of Ethiopia,
and has a projected total population of 582,552. In 2009,
about 24, 554 all form of TB cases were registered in
SNNPR. It has one general hospital, 21 health centers,
175 health posts and 404 health professionals. The po-
tential health coverage i.e. access to health services when
needed and avoid financial hardship in paying for those
services of the zone is 91%. DOTs service is provided in
17 health centers and one General hospital. Data were
collected from all these health facilities: Tercha General
Hospital, Bale health center (HC), Dali HC, Hagle HC,
Tocha HC, Mari HC, Waka HC, Gessa HC, Loma HC,
Yello HC, Wara HC, Wh HC, Kechi HC, Boka HC,
Kerwo HC, Duga HC, Dash HC and Gendo HC between
February and April 2013.
The study population included pulmonary Tb patients
who registered 6 months before data collection time on
anti-Tb treatment regime. Patients on MDR treatment
regimen and patients too ill to be interviewed were ex-
cluded from the study. The sample size was calculated
via OpenEpi 2.3 software using a single population pro-
portion calculation formula using the following assump-
tions: 20% proportion of non adherence towards ant-Tb
treatment [17], 95% confidence level, 5% margin of error
and 10% non-response rate. The total calculated sample
yielded 271. Using sampling frame of records, simple
random sampling technique was used to recruit the
study participants. For qualitative data, 14 individuals (7
healthcare providers, 4 Tb patients and 3 health exten-
sion workers) were selected purposefully from the hos-
pital and health centers.
Variables in the study and its measurement
Anti-Tb treatment adherence status was the response
variable dichotomized as adherent and non adherent. A
patient belonging to either intensive or continuation
phase under new or retreatment regimen who missed
≥10% of the total prescribed dose was considered as
non-adherent. For sputum follow up, patient who missed
one and more sputum test will be considered as non-
adherent. The covariates included: sex, age, religion, eth-
nicity, level of education, occupation, marital status,
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having treatment supporter, type of transportation, atti-
tude of care providers, alcohol consumption, cigarette
smoking, having patient supervisor, availability of health
information at every visit, side effect of medication,
current treatment phase, pill burden, knowledge about
Tb and its treatment, distance from DOT center, travel-
ing time and Cost of medication other than anti-Tb.
History of smoking and history of alcohol consump-
tion has been assessed as during lifetime. We asked par-
ticipants to report their lifetime experiences of cigarette
smoking and alcohol drinking. We recorded their re-
sponse as smoker, non-smoker and ex-smoker for
cigarette smoking; drinker or non- drinker for alcohol
drinking. For statistical analysis, smoking responses was
further aggregated to yes or no. Knowledge towards Tb
and its treatment was assessed using knowledge related
questions and was classified as poor, fair and good.
Scores ≥75%, 74-60% and <60%, respectively, were la-
beled as good, fair and poor knowledge.
Data collection
Face-to-face interviews were conducted by six registered
nurses and supervised by three health officers to solicit
socio-demographic and economic factors, treatment re-
lated factors, behavioral factors and patient knowledge
towards tuberculosis and its treatment. The interviews
were conducted in a quiet room at the Tb clinic where
patients came for follow up checkup. Study subjects who
lost from follow-up were interviewed at home. Qualita-
tive data were collated through notes and audio-
recordings during interview. We used in-depth interview
guide to explore barriers related with current Tb control
programs and possible reasons for treatment non-
adherence.
Statistical analysis
Quantitative data were analyzed using descriptive and
inferential statistical techniques. Summary statistics in-
cluding percentages and odds ratios were computed. We
used binary logistic regression to analyze factors that
were associated with adherence to anti-Tb medications.
The analyses of bivariate logistic regression assessment
were conducted to check the existence of crude associ-
ation and select the candidate variables (P < 0.25 was
considered).
We checked multi-collinearity among selected inde-
pendent variables via variance inflation factor (VIF) and
none was found. Multiple logistic regression analysis was
used to declare the independently associated predictors.
P-value ≤0.05 was considered as a cut off point for stat-
istical significance in the final model. Goodness of fit of
the final model was checked by Hosmer and Lemeshow
[18] and was found fit. The Data were summarized using
odds ratio (OR) and 95% confidence interval. All
analyses were conducted in Statistical Package for the
Social Sciences (SPSS) version 16.0 for windows [19].
Qualitative data were analysed using thematic frame-
work analysis [20–22]. We conducted the following six
steps: i) Transcriptions were carried out from the audio-
taped interviews; ii) All transcripts were repeatedly read
by all authors to familiarize with the data; iii) After care-
ful reading, codes were developed so that similar codes
would be grouped together into categories: the analysis
was both deductive and inductive type to establish codes
known apriority and newly emerged from the data; iv)
Working analytical framework was developed while
grouping similar codes into categories; v) data were
summarized by category from each transcript using a
matrix spreadsheet, a process called charting; vi) inter-
preting the data was the last step. Findings from pa-
tients, health professionals and health extension workers
were triangulated. This helps to the validity of the data
and show conflicting views.
Results
Socio-demographic and clinical characteristics of
respondents
A total of 261 (96.3%) Tb patients were considered eli-
gible: 36 patients from hospital and 225 from health cen-
ters. Data of 10 study subjects were not included in the
analysis due to changing of place of residence, death and
incompleteness. Table 1 shows demographic and clinical
profile of the respondents. Males were slightly over-
represented (53.6%) and almost one third (32.6%) of the
respondents represented youths aged between 15 and
24 years. Half (50.2%) of the respondents followed
orthodox Christian and two third (65%) of the respon-
dents were married. Two out of five (43.9%) respondents
didn’t attend a school, and about 33% of respondents
were housewives. Majority (60.2%) of the patients were
pulmonary Tb positive, and almost all (98%) were cate-
gorized as new patients. Nearly two-third of patients
were in the intensive phase of Tb treatment. Prevalence
of Tb/HIV co-infection in the current study was 3.1%.
Prevalence of anti-Tb non adherence
The prevalence of anti-Tb non-adherence was 24.5%.
Among the total non-adherents, 36 were males, 36 were
pulmonary Tb positive, and 32 were under intensive
phase when analyzed by sex, Tb classification and treat-
ment phase respectively.
Barriers of anti-Tb treatment adherence among pulmonary
Tb patients
Table 2 presents findings of bivariate logistic regression
analysis between socio-demographic and economic fac-
tors and non-adherence towards anti-Tb medication.
Table 3 presents bivariate logistic regression analysis of
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clinical factors with non-adherence towards anti-Tb
medication. According to the bivariate logistic regression
analyses, level of education and occupational status were
the only statistically significant demographic variables.
Type of transportation, attitude of health care providers,
having a patient supervisor, availability of health infor-
mation at every visit, side effect of medication, current
treatment phase, pill burden, knowledge, cost of medica-
tion other than anti-Tb, distance and travelling time
were statistically significant clinical variables.
Table 4 presents the multiple logistic regression analysis
with non-adherence towards anti-Tb medication. Logistic
regression analyses demonstrated the following factors
statistically associated with non-adherence: having poor
level of knowledge, absence of health information at every
visit, pill burden, distance to Tb clinic beyond 10 km, and
cost of medication other than anti-Tb.
Tb patients who had poor knowledge about Tb and its
treatment were 5 times (AOR = 4.6, 95%CI: 1.4-15.6)
higher at risk towards anti-Tb non-adherence than those
who had good knowledge. The relative probability of
anti-Tb non-adherence among patients travelled more
than 10 km to pick treatments was higher than
(AOR = 5.7, 95% CI: 1.9–16.8) those travelled less than
10 km. The association of anti-Tb non-adherence among
patients who didn’t get health information at every visit
was 3 times (AOR = 3; 95% CI: 1.1–8.4) higher than
among those who got. Cost of medication other than Tb
was found a risk factor (AOR = 4.7, 95%CI: 1.7-13.4) to
anti-Tb non-adherence.
Findings of the qualitative study also supported the
quantitative results. The respondents stated that there
was an improvement of the program. However, they re-
ported that the service is not decentralized, lack of drugs
in stock was still observed and shortage of laboratory re-
agents for AFB was becoming a routine challenge.
Table 1 Demographic and clinical characteristics of pulmonary
TB patients in Dawouro Zone public health care facilities, South
West Ethiopia, 2012/2013
Characteristics Number, n Percent
Sex
Male 140 53.6
Female 121 46.4
Age (years)
15-24 85 32.6
25-34 80 30.7
35-44 54 20.7
≥ 45 42 16.0
Marital status
Married 170 65.0
Single 80 30.7
Widowed 7 2.7
Divorced 3 1.2
Separated 1 0.4
Religions
Orthodox 131 50.2
Protestants 125 47.9
Catholic 5 1.9
Ethnicity
Dawuro 245 93.9
Wolayta 10 3.8
Others a 6 2.3
Educational status
Illiterate 112 42.9
Able only to read/write 26 10.0
First cycle 58 22.2
Second cycle 36 13.8
Preparatory 7 2.7
College/university 22 8.4
Occupational status
Housewife 85 32.6
Farmer 79 30.3
Student 57 21.8
Government employee 31 11.9
Others b 9 3.4
Disease classification
Pulmonary TB positive 157 60.2
Pulmonary TB negative 104 39.8
Patients category
New 256 98.0
Treatment failure 2 0.8
Relapse 2 0.8
Return after default 1 0.4
Table 1 Demographic and clinical characteristics of pulmonary
TB patients in Dawouro Zone public health care facilities, South
West Ethiopia, 2012/2013 (Continued)
Treatment phase
Intensive phase 163 62.5
Continuation phase 98 37.5
Treatment regimen
New patient treatment regimen 256 98.1
Retreatment patient regimen 5 1.9
HIV status
Sero-negative 232 88.9
Sero- positive 8 3.1
Unspecified 21 8.0
a Amhara, Wolayta, Kambata, Hadeya; b Merchants, house maid
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Distance, lack of awareness about importance of treat-
ment completion and cost of transportation were the ex-
plored barriers for adherence. Decentralization of drug
pick-ups and delivering health information at every visit
were the suggested solutions. Table 5 presents some of
the quotes responded by the participants.
Discussion
Adherence to TB treatment is fundamental for success-
ful TB control and eradication. Nonetheless, the long-
term course of the treatment might expose patients for
non-adherence [23]. In the current study, only 75.5% of
participants were able to adhere to anti-Tb regimen,
which was lower than the reported adherence rates in
North East Ethiopia (77.5) [14] and Southwest Ethiopia
(79.2%) [24]. We argue that, these differences in findings
could be due to variations in definitions of anti-Tb non-
adherence. No gold standard definition of adherence to-
wards ant-Tb treatment is yet available although quan-
tity and timing of missed medication or hospital
appointments were recommended by WHO. In our
study, patients who missed 10% or more of their pre-
scribed doses of anti-Tb drugs were considered as non-
adherent while others measured non-adherence if pa-
tients discontinued medication for 6 days [25, 26].
In the current study, knowledge, distance, health infor-
mation at every visit, pill burden and cost of medication
other than anti-Tb were the predictors for anti-Tb treat-
ment non-adherence. Patients who had poor knowledge
towards Tb and its treatment were at risk of being non-
adherent. This was suggested by the qualitative findings
of the current study. The result was corroborated by
Table 2 Bivarate analysis of socio-demographic and economic factors of treatment non-adherence of pulmonary TB patients in pub-
lic health care facilities in Dawuro zone, Southwest Ethiopia, 2012/2013
Variables Adherents
Numbers (%)
Non-adherents
Numbers (%)
COR (95%CI) P value
Sex
Female 93(76.9) 28(23.1) 1
Male 104(74.3) 36(25.7) 1.2(0.7-2.0) 0.6
Age (years)
15-24 67 (78.8) 18(21.2) 1
25-34 60(75.0) 20(25.0) 1.2(0.6-2.6) 0.6
35-44 39(72.2) 15(27.8) 1.4(0.7-3.2) 0.4
≥ 45 31(73.8) 11(26.2) 1.3(0.6-3.1) 0.5
Marital status
Single 63(78.8) 17(21.2) 1
Married 126(74.1) 44(25.9) 1.3(0.7-2.5) 0.4
Divorced& widowed 8(72.7) 3(27.3) 1.4(0.3-5.8) 0.7
Religions
Orthodox 100(76.3) 31(23.7) 1
Others a 97(74.6) 33(25.4) 1.1(0.6-1.9) 0.8
Ethnicity
Dawouro 186(75.9) 59(24.1) 1
Others b 11(68.8) 5(31.2) 1.4(0.5-4.3) 0.5
Educational status
Formal education 101(82.1) 22(17.9) 1
Non-formal education 96(69.6) 42(30.4) 2.1(1.1-3.6) 0.02*
Occupational status
Gov. employee 28(90.3) 3(9.7) 1
Housewife 62(72.9) 23(27.1) 3.5(0.9-12.3) 0.05*
Farmers 52(65.8) 27(34.2) 4.9(1.4-17.3) 0.02*
Others c 55(83.3) 11(16.7) 1.9(0.5-7.2) 0.4
AOR adjusted odds ratio, COR crude odds ratio, CI confidence interval
* Statistically significant at P-value below 0.05
a Protestant, Catholic; b Amhara, Wolayta, Kambata, Hadeya; c Merchants, house maid
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Table 3 Bivarate analysis of clinical predictors of anti-TB treatment non-adherence of pulmonary TB patients in public health care
facilities, Dawuro Zone, South west Ethiopia, 2012/2013
Variables Adherents
No (%)
Non-adherents
No (%)
COR (95%CI) P Value
Having treatment supporter
Yes 181(77.0) 54(23.0) 1
No 16(61.5) 10(38.5) 2.1(1.0-4.9) 0.087
Type of transportation
Walking 173(83.2) 35(16.8) 1
Use own transport 11(44.0) 14(56.0) 6.3(2.6-15.0) <0.001*
Use public transport 11(42.3) 15(57.7) 6.7(2.9-15.9) <0.001
Attitude of care providers
Care friendly 180(78.3) 50(21.7) 1
Care unfriendly 17(54.8) 14(45.2) 3.0(1.4-6.4) 0.01*
Alcohol consumption
No 186(76.9) 56(23.1) 1
Yes 11(57.9) 8(42.1) 2.4(0.9-6.3) 0.07
Having patient supervisor
Yes 177(77.0) 53(23.0) 1
No 5(35.7) 9(64.3) 6.0(1.9-18.7) 0.002*
Getting health education at every visit
Yes 130(88.4) 17(11.6) 1
No 67(58.8) 47(41.2) 5.4(2.9-10.1) <0.001*
Medication side effect
Absent 176(77.9) 50(22.1) 1
Presents 21(60.0) 14(40.0) 2.3(1.1-4.9) 0.025*
Current treatment phase
Continuation 134(80.7) 32(19.3) 1
Intensive 63(66.3) 32(33.7) 2.1(1.2-3.8) 0.01*
Pill burden
Absent 190(76.9) 57(23.1) 1
Present 7(50.0) 7(50.0) 3.3(1.1-9.9) 0.03*
Knowledge
Good 107(89.9) 12(10.1) 1
Fair 41(87.2) 6(12.8) 1.3(0.5-3.7) 0.09
Poor 49(51.6) 46(48.4) 8.4(4.1-17.2) <0.001*
Distance of DOT center
< 10 km 171(85.5) 29(14.5) 1
≥ 10 km 26(42.6) 35(57.4) 7.9(4.2-15.1) <0.001*
Traveling time
< 60 min 122(86.5) 19(19.5) 1
≥ 60 min 75(62.5) 45(37.5) 3.9(2.1-7.1) <0.001*
Cost of medication other than anti-Tb
No 143(92.9) 11(7.1) 1
Yes 54(50.5) 53(49.5) 12.7(6.2-26.2) <0.001*
AOR adjusted odds ratio, COR crude odds ratio, CI confidence interval
* Statistically significant at P-value below 0.05
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Table 4 Multivariable Logistic regression model to identify independent predictor’s of treatment non-adherence of pulmonary TB
patients in public health care facilities in Dawuro Zone, South west Ethiopia, 2012/2013
Variables Adherents
No (%)
Non-adherent
No (%)
COR (95%CI) AOR (95%CI)
Educational status
Formal education 101(82.1) 22(17.9) 1 1
Non-formal education 96(69.6) 42(30.4) 2.1(1.1-3.6) 0.6(0.2-2.4)
Occupational status
Gov. employee 28(90.3) 3(9.7) 1 1
Housewife 62(72.9) 23(27.1) 3.5(0.9-12.3) 1.8(0.3-11.9)
Farmers 52(65.8) 27(34.2) 4.9(1.4-17.3) 1.7(0.2-19.6)
Others a 55(83.3) 11(16.7) 1.9(0.5-7.2) 1.3(0.2-7.2)
Treatment supporter
Present 181(77.0) 54(23.0) 1 1
Absent 16(61.5) 10(38.5) 2.1(1.0-4.9) 2.8(0.6-12.3)
Knowledge
Good 107(89.9) 12(10.1) 1 1
Fair 41(87.2) 6(12.8) 1.3(0.5-3.7) 3.8(0.7-20.4)
Poor 49(51.6) 46(48.4) 8.4(4.1-17.2) 4.6(1.4-15.6)*
Attitude of care providers
Care friendly 180(78.3) 50(21.7) 1 1
Care unfriendly 17(54.8) 14(45.2) 3.0(1.4-6.4) 1.2(0.3-5.9)
Traveling time
< 60 min 122(86.5) 19(19.5) 1 1
≥ 60 min 75(62.5) 45(37.5) 3.9(2.1-7.1) 1.7(0.5-5.1)
Patient taking alcohol
No 186(76.9) 56(23.1) 1 1
Yes 11(57.9) 8(42.1) 2.4(0.9-6.3) 1.2(0.1-11.5)
Patient has supervisor
Yes 177(77.0) 53(23.0) 1 1
No 5(35.7) 9(64.3) 6.0(1.9-18.7) 0.5(0.04-5.9)
Health information at every visit
Yes 130(88.4) 17(11.6) 1 1
No 67(58.8) 47(41.2) 5.4(2.9-10.1) 3.0(1.1-8.4)*
Medication side effect
Absent 176(77.9) 50(22.1) 1 1
Presents 21(60.0) 14(40.0) 2.3(1.1-4.9) 1.7(0.4-7.1)
Current treatment phase
Continuation 134(80.7) 32(19.3) 1 1
Intensive 63(66.3) 32(33.7) 2.1(1.2-3.8) 1.7(0.6-4.5)
Pill burden
Absent 190(76.9) 57(23.1) 1 1
Present 7(50.0) 7(50.0) 3.3(1.1-9.9) 6.1(1.0-36.9)*
Distance of DOT center
< 10 km 171(85.5) 29(14.5) 1 1
≥ 10 km 26(42.6) 35(57.4) 7.9(4.2-15.1) 5.7(1.9-16.8)*
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findings of previous studies [27–29]. This might plaus-
ibly be justified by that majority of the respondents were
also illiterate. This cues an action to increase awareness
about the disease and its treatment. It is well known that
education increases knowledge, health awareness and
treatment seeking behavior of individuals [30]. Accord-
ing to both quantitative and qualitative findings of the
current study, distance was another barrier for anti-Tb
treatment non-adherence, a finding that was similarly re-
ported by studies done elsewhere [15, 28, 31]. This heed
the need for decentralization of DOTs service to health
post- the lowest level of health facility structure in
Ethiopia.
Cost of medication other than anti-Tb remains another
serious challenge in Tb treatment non-adherence. This
was not dissimilar with the findings of previous studies
[30, 32]. This is because Ethiopia’s national Tb program
requires free provision of anti-Tb treatment and its exam-
ination [5, 33]. Nonetheless, this free Tb service policy did
not include drugs other than anti-Tb. For example, drugs
related to respiratory symptoms, liver protection, or ad-
verse effects associated with anti-Tb drugs are not cov-
ered. In addition, patients worry transportation and
accommodation costs. Decentralization of drug pick-ups
might reduce the burden. Health care financing progam
should also consider Tb patients to waive costs associated
with adverse reactions of anti-Tb drugs.
The study had some limitations, which were worth
noting. The institutional based nature of the study might
not infer for other Tb patients who didn’t visit the insti-
tution. Similarly, the nature of cross-sectional study de-
sign does not indicate temporal relationship or causality.
Self-report of adherence to medications could also be af-
fected by recall bias. Moreover, selection bias could also
have been introduced because patients who are under
regular follow-up by the university clinic are likely to be
receiving better care and support than those in the lower
level clinics. Health workers collected data through dir-
ect interview of patients and this may subject to social
desirability bias.
Conclusions
In conclusion, this current study assessed the degree of
adherence in pulmonary Tb patients receiving DOTS ther-
apy and barriers contributing to adherence. In comparison
to previous studies, our study revealed relatively high non-
adherence rate among new pulmonary Tb patients. Know-
ledge, distance, not decentralizing of DOTs service, health
information at every visit and cost of medication other
than anti-Tb were the barriers for anti-Tb treatment ad-
herence. Policies are recommended to be developed to
strengthen the treatment management of TB patients.
Where possible, decentralization of DOTs service to lower
level of health facility structure should be prioritized.
Table 4 Multivariable Logistic regression model to identify independent predictor’s of treatment non-adherence of pulmonary TB
patients in public health care facilities in Dawuro Zone, South west Ethiopia, 2012/2013 (Continued)
Cost of medication other than anti-Tb
No 143(92.9) 11(7.1) 1 1
Yes 54(50.5) 53(49.5) 12.7(6.2-26.2) 4.7(1.7-13.4)*
Type of transportation
Walking 173(83.2) 35(16.8) 1 1
Use own transport 11(44.0) 14(56.0) 6.3(2.6-15.0) 2.7(0.5-15.0)
Use public transport 11(42.3) 15(57.7) 6.7(2.9-15.9) 4.8(0.9-25.0)
* Statistically significant at P-value below 0.05
a Merchants, house maid
Table 5 Examples of interview extracts of Tb patients, health extension workers and health professionals concerning barriers for
anti-Tb non-adherence
Barriers for non-adherence Patient and health professionals citations
Distance and travelling cost “Against to the national tuberculosis guide line, we give at least two days medication to their home during
intensive phase…. to decrease the distance burden and traveling cost” TB clinic nurse from health center
“Treatment adherence of patient in our facilities is relatively improving but majorities of patients do not return
for sputum re-examination specially for 5th and 6th month check up due to distance” TB clinic nurse from
hospital
Drug pick-ups decentralization “To improve the patient’s adherence health post should provide the DOTS service. Health extension workers
are providing family planning service including injectable, so why not DOTS service?” Health extension worker
Distance, cost of transportation and DOTS
service decentralization
“Patients like me, who come from long distance can’t complete the treatment even if we have enough money.
Because, we have another business in our home. But if the service is near to my home, I know I can complete
the treatment easily. For example our health post is very close to me. Due to the absence of this access, we
are forced to travel this long distance and pay more than 40 ETB daily.” Patient from health center
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